NCT03526666View on ClinicalTrials.gov

Ascorbic Acid Levels in MDS, AML, and CMML Patients

CompletedOBSERVATIONAL
Enrollment

50

Participants

Timeline

Start Date

November 1, 2017

Primary Completion Date

October 31, 2018

Study Completion Date

October 31, 2018

Conditions
Myelodysplastic SyndromesAcute Myeloid LeukemiaChronic Myelomonocytic LeukemiaMDSAMLCMML
Interventions
OTHER

Peripheral blood collection

Peripheral blood collection for the measurement of ascorbic acid levels and banking of plasma and buffy coat for future resrearch.

Trial Locations (2)

49503

Cancer and Hematology Centers of Western Michigan, Grand Rapids

49519

Metro Health - University of Michigan Health, Wyoming

All Listed Sponsors
lead

Van Andel Research Institute

OTHER

NCT03526666 - Ascorbic Acid Levels in MDS, AML, and CMML Patients | Biotech Hunter | Biotech Hunter